13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Spine and Spinal Disorders
The spine stands as a complex structure composed of vertebrae, intervertebral discs, nerves, and ligaments, essential for stability, mobility, and spinal cord protection. Within this intricate framework lie various disorders, spanning from congenital anomalies to degenerative ailments and traumatic injuries. Among the commonly encountered issues are herniated discs, spinal stenosis, scoliosis, kyphosis, and spondylolisthesis, all of which manifest through symptoms like back pain, neck pain, and radiating discomfort into the limbs, alongside weakness and numbness. Left untreated, these disorders can progress, leading to neurological deficits and severe impairment of quality of life. Treatment modalities of spine and spinal disorders range from conservative measures such as physical therapy, medication, and injections to surgical interventions like spinal fusion, laminectomy, and discectomy, aimed at alleviating pain, decompressing neural structures, and restoring function. With advancements, minimally invasive techniques now offer improved outcomes, marked by smaller incisions and quicker recovery.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States